ScholarIQanswers from OpenAlex & ORCID
Christopher Rodman
ResearcherPublications, citations & collaboration network
Christopher Rodman is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Christopher Rodman have?
ScholarIQindexed works
Christopher Rodman has 51 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Christopher Rodman have?
ScholarIQcitation count
Christopher Rodman has 18,686 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Christopher Rodman?
ScholarIQh-index
Christopher Rodman has an h-index of 20 in OpenAlex.
What is the i10-index of Christopher Rodman?
ScholarIQi10-index
Christopher Rodman has an i10-index of 22 in OpenAlex.
What is the OpenAlex record for Christopher Rodman?
ScholarIQopenalex
The OpenAlex for Christopher Rodman is on the source record.
What are the most-cited papers on Christopher Rodman?
ScholarIQmost cited works
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh, Benjamin Izar, Sanjay M. Prakadan, Marc H. Wadsworth, Daniel J. Treacy, John J. Trombetta, Asaf Rotem, Christopher Rodman, Christine G. Lian, Gëorge F. Murphy, Mohammad Fallahi‐Sichani, Ken Dutton‐Regester, Jia‐Ren Lin, Ofir Cohen, Parin Shah, Diana Lu, Alex S. Genshaft, Travis K. Hughes, Carly G.K. Ziegler, Samuel W. Kazer, Aleth Gaillard, Kellie E. Kolb, Alexandra–Chloé Villani, Cory M. Johannessen, Aleksandr Andreev, Eliezer M. Van Allen, Monica M. Bertagnolli, Peter K. Sorger, Ryan J. Sullivan, Keith T. Flaherty, Dennie T. Frederick, Judit Jané‐Valbuena, Charles H. Yoon, Orit Rozenblatt–Rosen, Alex K. Shalek, Aviv Regev, Levi A. Garraway
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby‐Arnon, Parin Shah, Michael S. Cuoco, Christopher Rodman, Mei-Ju Su, Johannes C. Melms, Rachel Leeson, Abhay Kanodia, Shaolin Mei, Jia‐Ren Lin, Shu Wang, Bokang Rabasha, David Liu, Gao Zhang, Claire Margolais, Orr Ashenberg, Patrick A. Ott, Elizabeth I. Buchbinder, Rizwan Haq, F. Stephen Hodi, Genevieve M. Boland, Ryan J. Sullivan, Dennie T. Frederick, Benchun Miao, Tabea Moll, Keith T. Flaherty, Meenhard Herlyn, Russell W. Jenkins, Rohit Thummalapalli, Monika S. Kowalczyk, Israel Cañadas, Bastian Schilling, Adam N.R. Cartwright, Adrienne Luoma, Shruti Malu, Patrick Hwu, Chantale Bernatchez, Marie-Andrée Forget, David A. Barbie, Alex K. Shalek, Itay Tirosh, Peter K. Sorger, Kai W. Wucherpfennig, Eliezer M. Van Allen, Dirk Schadendorf, Bruce E. Johnson, Asaf Rotem, Orit Rozenblatt–Rosen, Levi A. Garraway, Charles H. Yoon, Benjamin Izar, Aviv Regev
Transcriptional mediators of treatment resistance in lethal prostate cancer
Meng Xiao He, Michael S. Cuoco, Jett Crowdis, Alice Bosma-Moody, Zhenwei Zhang, Kevin Bi, Abhay Kanodia, Mei-Ju Su, Sheng‐Yu Ku, Maria Mica Garcia, Amalia Sweet, Christopher Rodman, Laura DelloStritto, Rebecca Silver, John A. Steinharter, Parin Shah, Benjamin Izar, Nathan C. Walk, Kelly P. Burke, Ziad Bakouny, Alok K. Tewari, David Liu, Sabrina Y. Camp, Natalie I. Vokes, Keyan Salari, Jihye Park, Sébastien Vigneau, Lawrence Fong, Joshua W. Russo, Xin Yuan, Steven P. Balk, Himisha Beltran, Orit Rozenblatt–Rosen, Aviv Regev, Asaf Rotem, Mary‐Ellen Taplin, Eliezer M. Van Allen